TBI-166 - CAS 1353734-12-9

TBI-166, an orally active riminophenazine analogue, serves as an anti-tuberculosis agent and exhibits fewer adverse reactions compared to its lead compound, Clofazimine [1] [2] [3].

Antibacterial, Others

Microbiology/Virology, Others

1353713

C32H30F3N5O3

589.61

N(=C1C=C2N(C=3C(N=C2C=C1NC4=C(OC)N=CC=C4)=CC=CC3)C5=CC=C(OC(F)(F)F)C=C5)C6CCC(OC)CC6

-20°C

Ice Packs

Small Compound